Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists (MEL60)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02126579 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 30, 2014
Last Update Posted : October 4, 2019
|
Sponsor:
Craig L Slingluff, Jr
Collaborator:
University of Virginia
Information provided by (Responsible Party):
Craig L Slingluff, Jr, University of Virginia
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2021 |
| Estimated Study Completion Date : | May 2021 |